• by Ray Schultz , October 18, 2017

MiMedx Group, Inc., a biopharmaceutical company,  says outsiders are creating email accounts to impersonate its executives with the goal of hurting its stock price.  

At least one email has been sent by someone using the CEO’s name and a Gmail account that did not belong to the executive.

Chairman and CEO Parker H. "Pete" Petit claims that “this "activity is related to the recent short seller attacks on the company.”

He adds that the “ultimate goal is to depress the price of our stock.”

The company has reported the case to the authorities, it adds.